Eledon Pharmaceuticals
ELDN
ELDN
49 hedge funds and large institutions have $32.1M invested in Eledon Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-4
Holders Change %
-7.55%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
18
Reduced
12
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
KCM
51
Kingdon Capital Management
New York
| – | -$767K | -543 | Closed |
|
|
OPPM
52
Opus Point Partners Management
New York
| – | -$541K | -383 | Closed |
|
|
ARTA
53
A.R.T. Advisors
New York
| – | -$239K | -170 | Closed |
|
|
CS
54
Credit Suisse
Zurich,
Switzerland
| – | -$175K | -124 | Closed |
|
55
D.E. Shaw & Co
New York
| – | -$158K | -112 | Closed |
|
56
BNP Paribas Financial Markets
Paris,
France
| – | -$22.3K | -16 | Closed |
|
|
CG
57
Colony Group
Boston,
Massachusetts
| – | -$17K | -12 | Closed |
|
58
UBS Group
Zurich,
Switzerland
| – | -$11K | -8 | Closed |
|
|
TRCT
59
Tower Research Capital (TRC)
New York
| – | -$10K | -7 | Closed |
|
|
IA
60
IFP Advisors
Tampa,
Florida
| – | -$2K | -2 | Closed |
|